Posts

New study shows nutritional epigenetics education impro...

In a recent publication released by PubMed, American scientists led by Dr. Dufau...

Surprisingly vibrant colour of 12-million-year-old snai...

Snail shells are often colourful and strikingly patterned. This is due to pigmen...

In the Cerrado, crop diversification has beneficial eff...

There are no substitutes for native vegetation, but replacing large areas of mon...

Mechanistically based blood proteomic markers in the TG...

“A fundamental hypothesis we sought to test was whether biomarkers from the TGF-...

Quitting smoking at any age brings big health benefits,...

People who quit smoking see major gains in life expectancy after just a few year...

Discoveries can be used to optimize production of annat...

Researchers at the University of São Paulo’s Luiz de Queiroz College of Agricult...

New test for improving population-based colorectal canc...

Each year worldwide, approximately 1.9 million people are diagnosed with colorec...

Harnessing human evolution to advance precision medicine

Humans are still evolving, and Tatum Simonson, PhD, founder and co-director of t...

J&J’s Autoimmune Drug Prospect Meets Phase 3 Goal, Inch...

Johnson & Johnson’s recent triumph with its $6.5 billion autoimmune medication i...

Novartis spends €2.7 billion on acquiring MorphoSys

The recent buzz surrounding a potential bidding war for the cancer specialist Mo...

Verekitug by Upstream Bio for Rhinosinusitis: Likelihoo...

Verekitug is under clinical development by Upstream Bio and currently in Phase I...

Tapotoclax by Amgen for Myelodysplastic Syndrome: Likel...

Tapotoclax is under clinical development by Amgen and currently in Phase I for M...

Tapotoclax by Amgen for Chronic Myelomonocytic Leukemia...

Tapotoclax is under clinical development by Amgen and currently in Phase I for C...

Vorolanib by EyePoint Pharmaceuticals for Diabetic Macu...

Vorolanib is under clinical development by EyePoint Pharmaceuticals and currentl...

Monoclonal Antibody Conjugate 3 to Target EGFR for Onco...

Monoclonal Antibody Conjugate 3 to Target EGFR for Oncology is under clinical de...

(Edetate disodium + ethyl alcohol + minocycline hydroch...

(Edetate disodium + ethyl alcohol + minocycline hydrochloride) is under clinical...